These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26515125)

  • 1. Exemestane metabolites suppress growth of estrogen receptor-positive breast cancer cells by inducing apoptosis and autophagy: A comparative study with Exemestane.
    Amaral C; Lopes A; Varela CL; da Silva ET; Roleira FM; Correia-da-Silva G; Teixeira N
    Int J Biochem Cell Biol; 2015 Dec; 69():183-95. PubMed ID: 26515125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exemestane metabolites: Synthesis, stereochemical elucidation, biochemical activity and anti-proliferative effects in a hormone-dependent breast cancer cell line.
    Varela CL; Amaral C; Tavares da Silva E; Lopes A; Correia-da-Silva G; Carvalho RA; Costa SC; Roleira FM; Teixeira N
    Eur J Med Chem; 2014 Nov; 87():336-45. PubMed ID: 25277066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of steroidal aromatase inhibitors on sensitive and resistant breast cancer cells: aromatase inhibition and autophagy.
    Amaral C; Varela C; Azevedo M; da Silva ET; Roleira FM; Chen S; Correia-da-Silva G; Teixeira N
    J Steroid Biochem Mol Biol; 2013 May; 135():51-9. PubMed ID: 23318878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis and autophagy in breast cancer cells following exemestane treatment.
    Amaral C; Borges M; Melo S; da Silva ET; Correia-da-Silva G; Teixeira N
    PLoS One; 2012; 7(8):e42398. PubMed ID: 22912703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor efficacy of new 7α-substituted androstanes as aromatase inhibitors in hormone-sensitive and resistant breast cancer cells.
    Amaral C; Varela CL; Maurício J; Sobral AF; Costa SC; Roleira FMF; Tavares-da-Silva EJ; Correia-da-Silva G; Teixeira N
    J Steroid Biochem Mol Biol; 2017 Jul; 171():218-228. PubMed ID: 28396197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone-dependent breast cancer: Targeting autophagy and PI3K overcomes Exemestane-acquired resistance.
    Amaral C; Augusto TV; Tavares-da-Silva E; Roleira FMF; Correia-da-Silva G; Teixeira N
    J Steroid Biochem Mol Biol; 2018 Oct; 183():51-61. PubMed ID: 29791862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New cell culture model for aromatase inhibitor-resistant breast cancer shows sensitivity to fulvestrant treatment and cross-resistance between letrozole and exemestane.
    Hole S; Pedersen AM; Hansen SK; Lundqvist J; Yde CW; Lykkesfeldt AE
    Int J Oncol; 2015 Apr; 46(4):1481-90. PubMed ID: 25625755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Everolimus downregulates estrogen receptor and induces autophagy in aromatase inhibitor-resistant breast cancer cells.
    Lui A; New J; Ogony J; Thomas S; Lewis-Wambi J
    BMC Cancer; 2016 Jul; 16():487. PubMed ID: 27421652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential biological effects of aromatase inhibitors: Apoptosis, autophagy, senescence and modulation of the hormonal status in breast cancer cells.
    Augusto TV; Amaral C; Almeida CF; Teixeira N; Correia-da-Silva G
    Mol Cell Endocrinol; 2021 Nov; 537():111426. PubMed ID: 34391846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a combination of exemestane and paclitaxel on human tumor cells in vitro.
    Chen D; Hackl W; Ortmann O; Treeck O
    Anticancer Drugs; 2004 Jan; 15(1):55-61. PubMed ID: 15090744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Exemestane Derivative, Oxymestane-D1, as a New Multi-Target Steroidal Aromatase Inhibitor for Estrogen Receptor-Positive (ER
    Amaral C; Correia-da-Silva G; Almeida CF; Valente MJ; Varela C; Tavares-da-Silva E; Vinggaard AM; Teixeira N; Roleira FMF
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and aromatase inhibition by potential metabolites of exemestane (6-methylenandrosta-1,4-diene-3,17-dione).
    Buzzetti F; Di Salle E; Longo A; Briatico G
    Steroids; 1993 Nov; 58(11):527-32. PubMed ID: 8273115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression alterations associated with outcome in aromatase inhibitor-treated ER+ early-stage breast cancer patients.
    Thomsen KG; Lyng MB; Elias D; Vever H; Knoop AS; Lykkesfeldt AE; Lænkholm AV; Ditzel HJ
    Breast Cancer Res Treat; 2015 Dec; 154(3):483-94. PubMed ID: 26585578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential clinical benefit of targeting androgen receptor (AR) in estrogen-receptor positive breast cancer cells treated with Exemestane.
    Amaral C; Augusto TV; Almada M; Cunha SC; Correia-da-Silva G; Teixeira N
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165661. PubMed ID: 31891807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exemestane: treatment of breast cancer with selective inactivation of aromatase.
    Higa GM
    Am J Health Syst Pharm; 2002 Nov; 59(22):2194-2201; quiz 2202-4. PubMed ID: 12455303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exemestane in postmenopausal women with early or advanced breast cancer: a review.
    Bertelli G; Gangadhara S
    Expert Opin Pharmacother; 2010 Aug; 11(11):1933-42. PubMed ID: 20569090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial-catalysed derivatization of anti-cancer drug exemestane and cytotoxicity of resulting metabolites against human breast adenocarcinoma cell line (MCF-7) in vitro.
    Baydoun S; Wahab AT; Bano S; Imad R; Choudhary MI
    Steroids; 2016 Nov; 115():67-74. PubMed ID: 27521799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiproliferative effect of exemestane in lung cancer cells.
    Koutras A; Giannopoulou E; Kritikou I; Antonacopoulou A; Evans TR; Papavassiliou AG; Kalofonos H
    Mol Cancer; 2009 Nov; 8():109. PubMed ID: 19930708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence of Estrogen Receptor β modulates the response of breast cancer cells to therapeutic agents.
    Pons DG; Torrens-Mas M; Nadal-Serrano M; Sastre-Serra J; Roca P; Oliver J
    Int J Biochem Cell Biol; 2015 Sep; 66():85-94. PubMed ID: 26232188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effects of combined treatment with simvastatin and exemestane on MCF-7 human breast cancer cells.
    Shen Y; Du Y; Zhang Y; Pan Y
    Mol Med Rep; 2015 Jul; 12(1):456-62. PubMed ID: 25738757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.